Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis-Associated Neoplasia

Gastroenterology

Volumn 136, Issue 2, 2009, Pages

  Leedham, Simon J ^a,b   Graham, Trevor A ^a   Oukrif, Dahmane ^c   McDonald, Stuart A C ^a,d   Rodriguez Justo, Manuel ^c   Harrison, Rebecca F ^f   Shepherd, Neil A ^e   Novelli, Marco R ^c   Jankowski, Janusz A Z ^d   Wright, Nicholas A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^f LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MICROSATELLITE DNA; PROTEIN P53;

ANEUPLOIDY; ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; COLON POLYPOSIS; COLORECTAL CANCER; CRYPT CELL; DISEASE ASSOCIATION; DYSPLASIA; FOUNDER EFFECT; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MOLECULAR CLONING; ONCOGENE K RAS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 58649117763     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.10.086     Document Type: Article

References (29)

1. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
2. Itzkowitz S.H., and Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287 (2004) G7-G17
3. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
4. Leedham S.J., Jankowski J.A., Wright N.A., et al. Genetics of inflammatory bowel disease and associated cancers. Curr Colorectal Cancer Rep 2 (2006) 191-199
5. Willenbucher R.F., Zelman S.J., Ferrell L.D., et al. Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology 113 (1997) 791-801
6. Keller R., Foerster E.C., Kohler A., et al. Diagnostic value of DNA image cytometry in ulcerative colitis. Dig Dis Sci 46 (2001) 870-878
7. Befrits R., Hammarberg C., Rubio C., et al. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum 37 (1994) 313-320
8. Brentnall T.A., Crispin D.A., Rabinovitch P.S., et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107 (1994) 369-378
9. Leedham S.J., and Wright N.A. Human tumour clonality assessment-flawed but necessary. J Pathol 215 (2008) 351-354
10. Yoshida T., Mikami T., Mitomi H., et al. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts. J Pathol 199 (2003) 166-175
11. Leedham S.J., Preston S.L., McDonald S.A., et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 57 (2008) 1041-1048
12. Buhmeida A., Algars A., Ristamaki R., et al. DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer. Oncology 70 (2006) 427-437
13. Powell S.M., Zilz N., Beazer-Barclay Y., et al. APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992) 235-237
14. Chen R., Rabinovitch P.S., Crispin D.A., et al. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol 162 (2003) 665-672
15. Chen R., Rabinovitch P.S., Crispin D.A., et al. The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 26 (2005) 1513-1519
16. Takayama T., Ohi M., Hayashi T., et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121 (2001) 599-611
17. Yashiro M., Carethers J.M., Laghi L., et al. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 61 (2001) 2676-2683
18. Janssen K.P., Alberici P., Fsihi H., et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 131 (2006) 1096-1109
19. Sansom O.J., Meniel V., Wilkins J.A., et al. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc Natl Acad Sci U S A 103 (2006) 14122-14127
20. Janssen K.P., el-Marjou F., Pinto D., et al. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 123 (2002) 492-504
21. Slaughter D.P., Southwick H.W., and Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6 (1953) 963-968
22. Braakhuis B.J., Tabor M.P., Kummer J.A., et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63 (2003) 1727-1730
23. Lyda M.H., Noffsinger A., Belli J., et al. Microsatellite instability and K-ras mutations in patients with ulcerative colitis. Hum Pathol 31 (2000) 665-671
24. Lyda M.H., Noffsinger A., Belli J., et al. Multifocal neoplasia involving the colon and appendix in ulcerative colitis: pathological and molecular features. Gastroenterology 115 (1998) 1566-1573
25. Wong W.M., Mandir N., Goodlad R.A., et al. Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut 50 (2002) 212-217
26. Greaves L.C., Preston S.L., Tadrous P.J., et al. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci U S A 103 (2006) 714-719
27. Clausen O.P., Andersen S.N., Stroomkjaer H., et al. A strategy combining flow sorting and comparative genomic hybridization for studying genetic aberrations at different stages of colorectal tumorigenesis in ulcerative colitis. Cytometry 43 (2001) 46-54
28. Prevo L.J., Sanchez C.A., Galipeau P.C., et al. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 59 (1999) 4784-4787
29. Noble C.L., Abbas A.R., Cornelius J., et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 57 (2008) 1398-1405